In Vitro Diagnostics (IVD)

ELISA Immunoassay Chemiluminescence Immunoassay Molecular Diagnostics Point of Care Testing Cell Diagnostics

GB SARS CoV-2 IgG

An enzyme Immunoassay kit for in vitro qualitative detection of Antibody to SARS-CoV-2 spike protein in human serum. The test can be used prior and after SARS-CoV-2 vaccination to assess the immune status as well as an aid to diagnose and monitor infections by SARS-CoV-2 virus.

USEFUL RESOURCES

Add to List

> SPECIFICATION > PERFORMANCE > ORDERING INFORMATION

SPECIFICATION

Number of wells	96
Principle	Indirect
Assay format	Qualitative
Total incubation time	105 minutes
Sample type	Serum
Sample volume	10 μL
Reading wavelength	450nm
Storage	2-8°C
Certification	RUO / CE

PERFORMANCE

58 normal healthy patients with samples collected before COVID-19 outbreak were tested. The results are as follows：

PERFORMANCE	Test Positive	Test Negative
Confirmed Positive	0	58
Confirmed Negative	2	56

The diagnostic sensitivity is 100%；The diagnostic specificity is 96.55%

ORDERING INFORMATION

Catalogue No.	Product
4ECO101E	GB SARS-CoV-2 IgG - 96T